Clinical Trial Update: 5-HTP and Creatine for Depression R33 Phase [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study (R33) evaluating 5-HTP and creatine for major depressive disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• 5-HTP (5-hydroxytryptophan)
• Creatine (creatine)

Snippet

Sponsor: University of Utah | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING